AWMM
EBS icon

Aegis Wealth Management (Maryland)’s Emergent Biosolutions EBS Stock Holding History

Aegis Wealth Management (Maryland)’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,150
Closed -$134K – 124
2025
Q3 		$134K Hold
15,150
– – 0.07% 123
2025
Q2 		$73.6K Hold
15,150
– – 0.04% 113
2025
Q1 		$73.6K Hold
15,150
– – 0.04% 118
2024
Q4 		$145K Buy
+15,150
New +$139K 0.1% 108

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aegis Wealth Management (Maryland)'s EBS Position: Q4 2025 in Review

Aegis Wealth Management (Maryland) sold out of Emergent Biosolutions (EBS) in Q4 2025, closing a stake of 15,150 shares — an estimated $134K sold.

Aegis Wealth Management (Maryland) first reported a position in EBS in Q4 2024 and held it in 4 quarters. The position peaked at $145K in Q4 2024. 183 funds tracked by Wall St. Rank hold EBS as of Q4 2025.

  • Aegis Wealth Management (Maryland) reported no remaining Emergent Biosolutions position as of Q4 2025 after selling out during the quarter.
  • Aegis Wealth Management (Maryland) sold 15,150 Emergent Biosolutions shares in Q4 2025, an estimated $134K.
  • Aegis Wealth Management (Maryland) first reported a position in Emergent Biosolutions in Q4 2024 and held it in 4 quarters.
  • Aegis Wealth Management (Maryland)'s Emergent Biosolutions position peaked at $145K in Q4 2024.
  • 183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2025.

Based on Aegis Wealth Management (Maryland)'s 13F filing for Q4 2025, filed 14 Jan 2026.